NMI Matched Antibody Pair (804) (APMAB-804LY)

Hu, H., Li, B., Chen, H., Fan, G., Ye, Z., Ji, S., ... & Qin, Y. (2024). NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3‐IFIT3 axis. Molecular Carcinogenesis, 63(2), 195-208.

Feng, L., Li, W., Li, X., Li, X., Ran, Y., Yang, X., ... & Li, H. (2023). N‐MYC‐interacting protein enhances type II interferon signaling by inhibiting STAT1 sumoylation. The FASEB Journal, 37(12), e23281.

Li, L., Chen, S. N., Li, N., & Nie, P. (2022). Molecular characterization and transcriptional conservation of N-myc-interactor, Nmi, by type I and type II IFNs in mandarin fish Siniperca chuatsi. Developmental & Comparative Immunology, 130, 104354.

Zhang, W., Zhou, H., Cen, M., Ouyang, W., Chen, J., Xia, L., ... & Xu, F. (2022). N-myc and STAT interactor is a novel biomarker of severity in community-acquired pneumonia: a prospective study. Respiratory Research, 23(1), 1-11.

Banday, M. M., Kumar, A., Vestal, G., Sethi, J., Patel, K. N., O'Neill, E. B., ... & Sharma, N. S. (2021). N-myc-interactor mediates microbiome induced epithelial to mesenchymal transition and is associated with chronic lung allograft dysfunction. The Journal of Heart and Lung Transplantation, 40(6), 447-457.

Wu, S., Li, X., Chai, H., Feng, L., Li, W., & Li, H. (2021). Downregulation of N-myc interactor promotes cervical cancer cells growth by activating Stat3 signaling. Cell Biochemistry and Biophysics, 79, 103-111.

Ji, D., Feng, Y., Peng, W., Li, J., Gu, Q. O., Zhang, Z., ... & Sun, Y. (2020). NMI promotes cell proliferation through TGFβ/Smad pathway by upregulating STAT1 in colorectal cancer. Journal of Cellular Physiology, 235(1), 429-441.

Choi, J. E., Hyun, C. L., Jin, M. S., Lee, K. M., Moon, J. H., & Ryu, H. S. (2020). Downregulation of N-myc and STAT interactor protein predicts aggressive tumor behavior and poor prognosis in invasive ductal carcinoma. Journal of Breast Cancer, 23(1), 36-46.

Xia, J., Blank, M. L., Zhou, L. J., Wu, S. Z., Peng, H. J., & Boyle, J. P. (2020). Strain-specific disruption of interferon-stimulated N-myc and STAT interactor (NMI) function by Toxoplasma gondii type I ROP18 in human cells. Parasitology, 147(13), 1433-1442.

Xiong, L., Du, Y., Zhou, T., Du, B., Visalath, P., Lin, L., ... & Cai, W. (2019). N‐myc and STAT interactor correlates with severity and prognosis in acute‐on‐chronic liver failure of hepatitis B virus. Journal of Gastroenterology and Hepatology, 34(10), 1800-1808.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-NMI Recombinant Antibody (CBWJN-0242)

Mouse Anti-NMI Recombinant Antibody (9D8)

Mouse Anti-NMI Recombinant Antibody (1E6)

Mouse Anti-NMI Recombinant Antibody (1A8)

Mouse Anti-NMI Recombinant Antibody (3C6)

Mouse Anti-NMI Recombinant Antibody (2F3)

Mouse Anti-NMI Recombinant Antibody (2C1)

Mouse Anti-NMI Recombinant Antibody (9B8)

Mouse Anti-NMI Recombinant Antibody (9E8)

Mouse Anti-NMI Recombinant Antibody (10E5)

Isotype control